10. Berliner Symposium der GWQ

Heinrich Moisa

CURRENT POSITION

General Manager Oncology
Novartis Pharma GmbH, Germany

EDUCATION
2000: Master of Business Administration, MBA (Diplom-Kaufmann)

Concentration: Finance and Entrepreneurship European Business School Oestrich-Winkel

 

 

CAREER

Since 2008: Novartis

Since May 2019: Novartis Pharma GmbH, Germany General Manager Oncology

2017 – 2019: Novartis Pharma BV, Arnhem, Netherlands, Country President & General Manager Oncology

2016 – 2017: Novartis Sverige AB, Stockholm, Sweden

  • General Manager Oncology, Sweden
  • Head Market Access & External Affairs, Oncology, Nordics

2013 – 2016: Novartis Norge AS, Oslo, Norway, Oncology Business Unit Head

2008 – 2013: Novartis Pharmaceuticals USA, Inc., East Hanover, NJ, USA

  • Senior Director, Global Product Strategy, Afinitor Lifecycle Management
  • Director, Global Product Strategy, Afinitor NET & NET Alliance
  • Brand Director (USA), NET Alliance
  • Associate Director (USA), Sandostatin LAR/ SOM230

2007 – 2008: GPC Biotech Inc., Princeton, NJ, USA Director, Business Planning & Analysis

2006 – 2007: Monitor Group, Germany Management Consulting, Project Leader

2000 – 2005: GPC Biotech

  • Princeton, NJ, USA: Director, Financial Planning & Controlling
  • Cambridge, MA, USA: Senior Manager, Finance
  • Munich, Germany: Analyst, Finance

 

<< zurück